• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

成骨细胞系中骨形态发生蛋白-2和骨形态发生蛋白-4基因表达的调控

Modulation of bone morphogenetic protein-2 and bone morphogenetic protein-4 gene expression in osteoblastic cell lines.

作者信息

Virdi A S, Cook L J, Oreffo R O, Triffitt J T

机构信息

Nuffield Department of Orthopaedic Surgery, University of Oxford, Nuffield Orthopaedic Centre, Headington, England.

出版信息

Cell Mol Biol (Noisy-le-grand). 1998 Dec;44(8):1237-46.

PMID:9874511
Abstract

Bone morphogenetic proteins (BMPs) belong to the transforming growth factor-beta (TGF-beta) superfamily and are crucial factors in the process of bone formation. Despite knowledge on their wide distribution and expression, however, there is very little information on the biological factors that affect gene transcription of these osteoinductive agents. To investigate this aspect of BMP gene regulation we have studied the effect of a number of factors known to affect osteogenic cells. Northern analysis showed modulation of the expression of BMP-2 and BMP-4 mRNAs in two human osteosarcoma cell lines, MG63 and Saos-2, by prostaglandin E2 (PGE2), interleukin-1beta (IL-1beta), interleukin-6 (IL-6), interferon-alpha (IFN-alpha), retinoic acid and 1,25(OH)2 vitamin D3. mRNA expressions of the normally used "housekeeping genes", glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and beta-actin, were found to be susceptible to influence by some of the factors used. Hence, an oligo(dT)15-18 probe was used to reliably estimate the relative quantities of mRNA present for normalization of data. In general, all factors down-regulated mRNA expressions of BMP-2 and BMP-4 in MG63 cells. IL-6 completely abolished detectable expression of BMP-2 mRNA, which was also greatly reduced by IL-1beta, retinoic acid and 1,25(OH)2 vitamin D3. PGE2 had similar influences on BMP-2 and BMP-4 expressions, showing reductions to approximately 60% of normal. In Saos-2 cells only 1,25(OH)2 vitamin D3 had any great effect on BMP-2 expression, which was down-regulated to approximately 60% of control values. BMP-4 was down-regulated by IFN-alpha (approximately 60%) and IL-1beta (approximately 20%). We conclude that BMPs are subject to regulation by a variety of factors and that this is dependent on the stage of the cell in the osteogenic lineage. Furthermore, the use of GAPDH and beta-actin genes as "housekeeping genes" in expression-modulation studies must be treated with care.

摘要

骨形态发生蛋白(BMPs)属于转化生长因子-β(TGF-β)超家族,是骨形成过程中的关键因子。然而,尽管已知它们分布广泛且有表达,但关于影响这些骨诱导因子基因转录的生物学因素的信息却非常少。为了研究BMP基因调控的这一方面,我们研究了一些已知影响成骨细胞的因素的作用。Northern分析显示,前列腺素E2(PGE2)、白细胞介素-1β(IL-1β)、白细胞介素-6(IL-6)、干扰素-α(IFN-α)、视黄酸和1,25(OH)2维生素D3对两种人骨肉瘤细胞系MG63和Saos-2中BMP-2和BMP-4 mRNA的表达有调节作用。发现常用的“管家基因”甘油醛-3-磷酸脱氢酶(GAPDH)和β-肌动蛋白的mRNA表达易受所用某些因素的影响。因此,使用寡聚(dT)15-18探针来可靠地估计存在的mRNA的相对量,以便对数据进行归一化。一般来说,所有因素均下调MG63细胞中BMP-2和BMP-4的mRNA表达。IL-6完全消除了可检测到的BMP-2 mRNA表达,IL-1β、视黄酸和1,25(OH)2维生素D3也使其大幅降低。PGE2对BMP-2和BMP-4的表达有类似影响,使其降低至正常水平的约60%。在Saos-2细胞中,只有1,25(OH)2维生素D3对BMP-2表达有显著影响,使其下调至对照值的约60%。BMP-4被IFN-α(约60%)和IL-1β(约20%)下调。我们得出结论,BMPs受到多种因素的调控,且这取决于成骨谱系中细胞的阶段。此外,在表达调控研究中使用GAPDH和β-肌动蛋白基因作为“管家基因”时必须谨慎对待。

相似文献

1
Modulation of bone morphogenetic protein-2 and bone morphogenetic protein-4 gene expression in osteoblastic cell lines.成骨细胞系中骨形态发生蛋白-2和骨形态发生蛋白-4基因表达的调控
Cell Mol Biol (Noisy-le-grand). 1998 Dec;44(8):1237-46.
2
Differential gene expression and regulation of the bone morphogenetic protein antagonists follistatin and gremlin in normal and osteoarthritic human chondrocytes and synovial fibroblasts.骨形态发生蛋白拮抗剂卵泡抑素和gremlin在正常及骨关节炎人类软骨细胞和滑膜成纤维细胞中的差异基因表达及调控
Arthritis Rheum. 2004 Aug;50(8):2521-30. doi: 10.1002/art.20441.
3
BMPs and BMPRs in chicken ovary and effects of BMP-4 and -7 on granulosa cell proliferation and progesterone production in vitro.鸡卵巢中的骨形态发生蛋白(BMPs)和骨形态发生蛋白受体(BMPRs)以及BMP-4和-7对体外颗粒细胞增殖和孕酮分泌的影响
Am J Physiol Endocrinol Metab. 2003 Nov;285(5):E973-83. doi: 10.1152/ajpendo.00104.2003. Epub 2003 Jul 29.
4
Bone morphogenetic protein-2 induces hypophosphorylation of Rb protein and repression of E2F in androgen-treated LNCaP human prostate cancer cells.骨形态发生蛋白-2在雄激素处理的LNCaP人前列腺癌细胞中诱导Rb蛋白低磷酸化并抑制E2F。
Int J Mol Med. 2005 Feb;15(2):253-8.
5
Bone morphogenetic protein-2 counterregulates interleukin-18 mRNA and protein in MC3T3-E1 mouse osteoblastic cells.骨形态发生蛋白-2在MC3T3-E1小鼠成骨细胞中对抗调节白细胞介素-18的mRNA和蛋白质。
Connect Tissue Res. 2006;47(3):124-32. doi: 10.1080/03008200600685350.
6
Bone morphogenetic protein-2 enhances osteoclast formation mediated by interleukin-1alpha through upregulation of osteoclast differentiation factor and cyclooxygenase-2.骨形态发生蛋白-2通过上调破骨细胞分化因子和环氧化酶-2增强白细胞介素-1α介导的破骨细胞形成。
Biochem Biophys Res Commun. 1999 May 27;259(1):97-102. doi: 10.1006/bbrc.1999.0715.
7
Lineage-restricted expression of bone morphogenetic protein genes in human hematopoietic cell lines.骨形态发生蛋白基因在人类造血细胞系中的谱系限制表达。
Blood Cells Mol Dis. 1999 Oct-Dec;25(5-6):310-23. doi: 10.1006/bcmd.1999.0259.
8
Quantitative analysis of gene expression in a rabbit model of intervertebral disc degeneration by real-time polymerase chain reaction.通过实时聚合酶链反应对兔椎间盘退变模型中的基因表达进行定量分析。
Spine J. 2005 Jan-Feb;5(1):14-23. doi: 10.1016/j.spinee.2004.05.251.
9
Bone morphogenetic protein-2 is a regulator of cell adhesion.骨形态发生蛋白-2是一种细胞黏附调节剂。
Exp Cell Res. 1997 Feb 1;230(2):377-85. doi: 10.1006/excr.1996.3438.
10
Involvement of the bone morphogenetic protein/receptor system during follicle development in the bovine ovary: Hormonal regulation of the expression of bone morphogenetic protein 7 (BMP-7) and its receptors (ActRII and ALK-2).骨形态发生蛋白/受体系统在牛卵巢卵泡发育过程中的作用:骨形态发生蛋白7(BMP-7)及其受体(激活素受体II型和激活素受体样激酶-2)表达的激素调节
Mol Cell Endocrinol. 2006 Apr 25;249(1-2):78-83. doi: 10.1016/j.mce.2006.01.015. Epub 2006 Mar 2.

引用本文的文献

1
Effect of Oral Alfacalcidol on Clinical Outcomes in Patients Without Secondary Hyperparathyroidism Receiving Maintenance Hemodialysis: The J-DAVID Randomized Clinical Trial.口服阿法骨化醇对无继发性甲状旁腺功能亢进接受维持性血液透析患者临床结局的影响:J-DAVID 随机临床试验。
JAMA. 2018 Dec 11;320(22):2325-2334. doi: 10.1001/jama.2018.17749.
2
Molecular analysis of enthesopathy in a mouse model of hypophosphatemic rickets.分子分析低磷血症性佝偻病小鼠模型中的腱末端病。
Development. 2018 Aug 10;145(15):dev163519. doi: 10.1242/dev.163519.
3
MicroRNA‑218 promotes prostaglandin E2 to inhibit osteogenic differentiation in synovial mesenchymal stem cells by targeting 15‑hydroxyprostaglandin dehydrogenase [NAD(+)].
微小 RNA-218 通过靶向 15-羟前列腺素脱氢酶 [NAD(+)] 促进前列腺素 E2 抑制滑膜间充质干细胞的成骨分化。
Mol Med Rep. 2017 Dec;16(6):9347-9354. doi: 10.3892/mmr.2017.7795. Epub 2017 Oct 17.
4
Comparative analysis of zebrafish bone morphogenetic proteins 2, 4 and 16: molecular and evolutionary perspectives.斑马鱼骨形态发生蛋白2、4和16的比较分析:分子与进化视角
Cell Mol Life Sci. 2016 Feb;73(4):841-57. doi: 10.1007/s00018-015-2024-x. Epub 2015 Sep 4.
5
Retinoic acids potentiate BMP9-induced osteogenic differentiation of mesenchymal progenitor cells.维甲酸增强骨髓间充质祖细胞诱导成骨分化。
PLoS One. 2010 Jul 30;5(7):e11917. doi: 10.1371/journal.pone.0011917.
6
CYR61 regulates BMP-2-dependent osteoblast differentiation through the {alpha}v{beta}3 integrin/integrin-linked kinase/ERK pathway.CYR61 通过 {alpha}v{beta}3 整联蛋白/整联蛋白连接激酶/ERK 通路调节 BMP-2 依赖性成骨细胞分化。
J Biol Chem. 2010 Oct 8;285(41):31325-36. doi: 10.1074/jbc.M109.087122. Epub 2010 Jul 30.
7
Endogenous bone morphogenetic proteins mediate 1alpha, 25-dihydroxyvitamin D(3)-induced expression of osteoblast differentiation markers in human dermal fibroblasts.内源性骨形态发生蛋白介导1α,25-二羟基维生素D(3)诱导人皮肤成纤维细胞中骨细胞分化标志物的表达。
J Orthop Res. 2009 Feb;27(2):162-8. doi: 10.1002/jor.20728.
8
Bone and mineral disorders in pre-dialysis CKD.透析前慢性肾脏病患者的骨与矿物质紊乱
Int Urol Nephrol. 2008;40(2):427-40. doi: 10.1007/s11255-008-9346-7.
9
Oral paricalcitol for the treatment of secondary hyperparathyroidism in chronic kidney disease.口服帕立骨化醇治疗慢性肾脏病继发性甲状旁腺功能亢进症。
Ther Clin Risk Manag. 2006 Sep;2(3):297-301. doi: 10.2147/tcrm.2006.2.3.297.
10
Nonclassical aspects of differential vitamin D receptor activation: implications for survival in patients with chronic kidney disease.维生素D受体激活差异的非经典方面:对慢性肾病患者生存的影响
Drugs. 2007;67(14):1999-2012. doi: 10.2165/00003495-200767140-00003.